SCHEDULE: AIGH Capital Management Discloses 3.9% Stake in Plus Therapeutics

AIGH Capital Management and Orin Hirschman have disclosed a 3.9% beneficial ownership stake in Plus Therapeutics, Inc., primarily through sole dispositive power over 1,283,681 shares including warrants.

Summary

• AIGH Capital Management LLC, AIGH Investment Partners, L.L.C., and Orin Hirschman (collectively, the "Reporting Persons") reported a beneficial ownership of 1,283,681 shares of Plus Therapeutics, Inc. common stock.
• This beneficial ownership represents 3.9% of the company's common stock outstanding.
• The reported shares include 1,283,681 Warrants to purchase common shares.
• The Reporting Persons hold sole dispositive power over all 1,283,681 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a routine beneficial ownership disclosure, indicating a passive stake below the 5% threshold, with no explicit positive or negative operational information.

Key Dates

Keywords

Plus Therapeutics, AIGH Capital Management, Orin Hirschman, Beneficial Ownership, Schedule 13G, Common Stock, Warrants, Investment Management